Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Joulin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Idiopathic acute partial renal infarction]Vincent Joulin, Federico Sallusto, Charles Deruelle, et al.
European Urology Focus|November 6, 2017
Long-term Patient-reported Clinical Outcomes and Reoperation Rate after Photovaporization with the XPS-180W GreenLight LaserJehanne Calves, Maxime Thoulouzan, Marie-Aimée Perrouin-Verbe, et al.
The Journal of Urology|September 23, 2003
Allelic losses in localized prostate cancer: association with prognostic factorsGaëlle Fromont, Vincent Joulin, Karine Chantrel-Groussard, et al.
Clinical Genitourinary Cancer|February 28, 2025
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic BiopsiesClaire Siebert, Truong-An Nguyen, Alexandre Fourcade, et al.
Urologic Oncology|June 30, 2023
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRITruong-An Nguyen, Alexandre Fourcade, Audrey Zambon, et al.
European Urology|November 10, 2006
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survivalXavier Taccoen, Antoine Valeri, Jean-Luc Descotes, et al.
Clinical Genitourinary Cancer|February 26, 2022
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate CancerKevin Saout, Audrey Zambon, Truong An Nguyen, et al.
Scandinavian Journal of Urology|February 22, 2018
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancerAlexandre Fourcade, Charlotte Payrard, Valentin Tissot, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Idiopathic acute partial renal infarction]Vincent Joulin, Federico Sallusto, Charles Deruelle, et al.
European Urology Focus|November 6, 2017
Long-term Patient-reported Clinical Outcomes and Reoperation Rate after Photovaporization with the XPS-180W GreenLight LaserJehanne Calves, Maxime Thoulouzan, Marie-Aimée Perrouin-Verbe, et al.
The Journal of Urology|September 23, 2003
Allelic losses in localized prostate cancer: association with prognostic factorsGaëlle Fromont, Vincent Joulin, Karine Chantrel-Groussard, et al.
Clinical Genitourinary Cancer|February 28, 2025
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic BiopsiesClaire Siebert, Truong-An Nguyen, Alexandre Fourcade, et al.
Urologic Oncology|June 30, 2023
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRITruong-An Nguyen, Alexandre Fourcade, Audrey Zambon, et al.
European Urology|November 10, 2006
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survivalXavier Taccoen, Antoine Valeri, Jean-Luc Descotes, et al.
Clinical Genitourinary Cancer|February 26, 2022
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate CancerKevin Saout, Audrey Zambon, Truong An Nguyen, et al.
Scandinavian Journal of Urology|February 22, 2018
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancerAlexandre Fourcade, Charlotte Payrard, Valentin Tissot, et al.
Pageof 1